Literature DB >> 21511009

Gender differences in the risk of familial parkinsonism: beyond LRRK2?

R Saunders-Pullman1, K Stanley, M San Luciano, M J Barrett, V Shanker, D Raymond, L J Ozelius, S B Bressman.   

Abstract

G2019S mutations in the LRRK2 gene are responsible for up to 18% of PD in individuals of Jewish descent. While a male preponderance of Parkinson disease (PD) has been consistently reported, this gender difference is not noted in LRRK2 G2019S mutation carriers. In order to test whether there is an increased genetic component in women of Jewish background in general, we examined family history of parkinsonism in 175 Jewish PD patients (82 female and 93 male) and assessed whether parkinsonism was more frequent in family members of women with PD in comparison with family members of men with PD, adjusting for LRRK2 G2019S mutations in the proband. Using Cox proportional hazard models to evaluate the risk of parkinsonism among family members of PD subjects, having a daughter with PD compared with a son was associated with increased risk of parkinsonism in the parent (HR 2.59, p=0.014) as was having a child with a LRRK2 G2019S mutation (HR 3.19, p=0.003). The increased risk among parents of women with PD persisted when adjusting for LRRK2 status (HR 2.19, p=0.023). Among individuals of Jewish descent, there is a relatively greater genetic load in women with PD, and this is not fully accounted for by the G2019S mutation. Further study that evaluates family information bias and assesses the role of glucocerebrosidase mutations is indicated.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21511009      PMCID: PMC3111955          DOI: 10.1016/j.neulet.2011.03.098

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  33 in total

Review 1.  Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both?

Authors:  Rachel Saunders-Pullman
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

2.  Validity of family history data on PD: evidence for a family information bias.

Authors:  A Elbaz; S K McDonnell; D M Maraganore; K J Strain; D J Schaid; J H Bower; J E Ahlskog; W A Rocca
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

Review 3.  Nonmotor symptoms in genetic Parkinson disease.

Authors:  Meike Kasten; Lena Kertelge; Norbert Brüggemann; Joyce van der Vegt; Alexander Schmidt; Vera Tadic; Carsten Buhmann; Susanne Steinlechner; Maria Isabel Behrens; Alfredo Ramirez; Ferdinand Binkofski; Hartwig Siebner; Heiner Raspe; Johann Hagenah; Rebekka Lencer; Christine Klein
Journal:  Arch Neurol       Date:  2010-06

4.  Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation.

Authors:  Denise M Kay; Patricia Kramer; Don Higgins; Cyrus P Zabetian; Haydeh Payami
Journal:  Mov Disord       Date:  2005-08       Impact factor: 10.338

Review 5.  Parkinson's disease and family history.

Authors:  Annabella N Sellbach; Richard S Boyle; Peter A Silburn; George D Mellick
Journal:  Parkinsonism Relat Disord       Date:  2006-06-22       Impact factor: 4.891

6.  "Familial Parkinson's disease"--a case-control study of families.

Authors:  R J Uitti; H Shinotoh; M Hayward; M Schulzer; E Mak; D B Calne
Journal:  Can J Neurol Sci       Date:  1997-05       Impact factor: 2.104

7.  Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging.

Authors:  M Baldereschi; A Di Carlo; W A Rocca; P Vanni; S Maggi; E Perissinotto; F Grigoletto; L Amaducci; D Inzitari
Journal:  Neurology       Date:  2000-11-14       Impact factor: 9.910

8.  A family history of Parkinson's disease and its effect on other PD risk factors.

Authors:  B A Rybicki; C C Johnson; E L Peterson; G X Kortsha; J M Gorell
Journal:  Neuroepidemiology       Date:  1999       Impact factor: 3.282

9.  Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease.

Authors:  Filip Simunovic; Ming Yi; Yulei Wang; Robert Stephens; Kai C Sonntag
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

Review 10.  Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson's disease: A contribution to sex-specific neuroprotection by estrogens.

Authors:  Glenda E Gillies; Simon McArthur
Journal:  Horm Behav       Date:  2009-06-16       Impact factor: 3.587

View more
  15 in total

1.  Risk factors for Parkinson's disease may differ in men and women: an exploratory study.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; J Eric Ahlskog; Walter A Rocca
Journal:  Horm Behav       Date:  2012-06-08       Impact factor: 3.587

2.  Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium.

Authors:  Karen Marder; Yuanjia Wang; Roy N Alcalay; Helen Mejia-Santana; Ming-Xin Tang; Annie Lee; Deborah Raymond; Anat Mirelman; Rachel Saunders-Pullman; Lorraine Clark; Laurie Ozelius; Avi Orr-Urtreger; Nir Giladi; Susan Bressman
Journal:  Neurology       Date:  2015-06-10       Impact factor: 9.910

3.  The complexities of hormonal influences and risk of Parkinson's disease.

Authors:  Connie Marras; Rachel Saunders-Pullman
Journal:  Mov Disord       Date:  2014-04-30       Impact factor: 10.338

4.  Gender differences in the IL6 -174G>C and ESR2 1730G>A polymorphisms and the risk of Parkinson's disease.

Authors:  M San Luciano; L Ozelius; R B Lipton; D Raymond; S B Bressman; R Saunders-Pullman
Journal:  Neurosci Lett       Date:  2011-12-01       Impact factor: 3.046

5.  Estimation of genetic risk function with covariates in the presence of missing genotypes.

Authors:  Annie J Lee; Karen Marder; Roy N Alcalay; Helen Mejia-Santana; Avi Orr-Urtreger; Nir Giladi; Susan Bressman; Yuanjia Wang
Journal:  Stat Med       Date:  2017-06-27       Impact factor: 2.373

Review 6.  The relevance of gender in Parkinson's disease: a review.

Authors:  Marina Picillo; Alessandra Nicoletti; Vincenza Fetoni; Barbara Garavaglia; Paolo Barone; Maria Teresa Pellecchia
Journal:  J Neurol       Date:  2017-01-04       Impact factor: 4.849

7.  Incidence of dementia with Lewy bodies and Parkinson disease dementia.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; Bradley F Boeve; J Eric Ahlskog; Walter A Rocca
Journal:  JAMA Neurol       Date:  2013-11       Impact factor: 18.302

8.  Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; J Eric Ahlskog; Walter A Rocca
Journal:  JAMA Neurol       Date:  2013-07       Impact factor: 18.302

9.  Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.

Authors:  Roy N Alcalay; Anat Mirelman; Rachel Saunders-Pullman; Ming-X Tang; Helen Mejia Santana; Deborah Raymond; Ernest Roos; Martha Orbe-Reilly; Tanya Gurevich; Anat Bar Shira; Mali Gana Weisz; Kira Yasinovsky; Maayan Zalis; Avner Thaler; Andres Deik; Matthew James Barrett; Jose Cabassa; Mark Groves; Ann L Hunt; Naomi Lubarr; Marta San Luciano; Joan Miravite; Christina Palmese; Rivka Sachdev; Harini Sarva; Lawrence Severt; Vicki Shanker; Matthew Carrington Swan; Jeannie Soto-Valencia; Brooke Johannes; Robert Ortega; Stanley Fahn; Lucien Cote; Cheryl Waters; Pietro Mazzoni; Blair Ford; Elan Louis; Oren Levy; Llency Rosado; Diana Ruiz; Tsvyatko Dorovski; Michael Pauciulo; William Nichols; Avi Orr-Urtreger; Laurie Ozelius; Lorraine Clark; Nir Giladi; Susan Bressman; Karen S Marder
Journal:  Mov Disord       Date:  2013-10-15       Impact factor: 10.338

Review 10.  A Practical Approach to Early-Onset Parkinsonism.

Authors:  Giulietta M Riboldi; Emanuele Frattini; Edoardo Monfrini; Steven J Frucht; Alessio Di Fonzo
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.